7OUR
Wilavidin apo form (P1 form)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE MASSIF-1 |
Synchrotron site | ESRF |
Beamline | MASSIF-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-10-11 |
Detector | DECTRIS PILATUS3 2M |
Wavelength(s) | 0.96546 |
Spacegroup name | P 1 |
Unit cell lengths | 50.320, 56.721, 62.641 |
Unit cell angles | 103.53, 110.75, 105.63 |
Refinement procedure
Resolution | 46.700 - 1.950 |
R-factor | 0.1823 |
Rwork | 0.180 |
R-free | 0.22590 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 7ouq |
RMSD bond length | 0.010 |
RMSD bond angle | 1.721 |
Data reduction software | autoPROC |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0238) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.700 | 2.000 |
High resolution limit [Å] | 1.950 | 1.950 |
Number of reflections | 40032 | 2788 |
<I/σ(I)> | 5.6 | |
Completeness [%] | 94.6 | |
Redundancy | 1.7 | |
CC(1/2) | 0.910 | 0.674 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 1.6 M sodium citrate tribasic pH 6.5 |